BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 28176243)

  • 1. The extent to which standardized uptake values reflect FDG phosphorylation in the liver and spleen as functions of time after injection of
    Keramida G; Anagnostopoulos CD; Peters AM
    EJNMMI Res; 2017 Dec; 7(1):13. PubMed ID: 28176243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tissue standardized uptake value is a closer surrogate of blood fluorine-18 fluorodeoxyglucose clearance after division by blood standardized uptake value, illustrated in brain and liver.
    Keramida G; Peters AM
    Nucl Med Commun; 2019 May; 40(5):552-554. PubMed ID: 30973842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of Static and Dynamic
    Braune A; Hofheinz F; Bluth T; Kiss T; Wittenstein J; Scharffenberg M; Kotzerke J; Gama de Abreu M
    J Nucl Med; 2019 Nov; 60(11):1629-1634. PubMed ID: 31053684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepato-splenic axis: hepatic and splenic metabolic activities are linked.
    Keramida G; Dunford A; Kaya G; Anagnostopoulos CD; Peters AM
    Am J Nucl Med Mol Imaging; 2018; 8(3):228-238. PubMed ID: 30042872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between regional hepatic glucose metabolism and regional distribution of hepatic fat.
    Dunford A; Keramida G; Singh N; Aplin M; Peters AM
    Nucl Med Commun; 2019 Mar; 40(3):212-218. PubMed ID: 30628944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of tumor volumes derived from glucose metabolic rate maps and SUV maps in dynamic 18F-FDG PET.
    Visser EP; Philippens ME; Kienhorst L; Kaanders JH; Corstens FH; de Geus-Oei LF; Oyen WJ
    J Nucl Med; 2008 Jun; 49(6):892-8. PubMed ID: 18483085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of hyperglycemia on brain and liver
    Viglianti BL; Wong KK; Wimer SM; Parameswaran A; Nan B; Ky C; Townsend DM; Rubello D; Frey KA; Gross MD
    Biomed Pharmacother; 2017 Apr; 88():1038-1045. PubMed ID: 28192877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative Analysis of Heterogeneous [
    Zhuang M; Karakatsanis NA; Dierckx RAJO; Zaidi H
    Mol Imaging Biol; 2019 Apr; 21(2):317-327. PubMed ID: 29956119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does whole-body Patlak
    Fahrni G; Karakatsanis NA; Di Domenicantonio G; Garibotto V; Zaidi H
    Eur Radiol; 2019 Sep; 29(9):4812-4821. PubMed ID: 30689031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative evaluation of SUV, tumor-to-blood standard uptake ratio (SUR), and dual time point measurements for assessment of the metabolic uptake rate in FDG PET.
    Hofheinz F; Hoff Jv; Steffen IG; Lougovski A; Ego K; Amthauer H; Apostolova I
    EJNMMI Res; 2016 Dec; 6(1):53. PubMed ID: 27334609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SUV varies with time after injection in (18)F-FDG PET of breast cancer: characterization and method to adjust for time differences.
    Beaulieu S; Kinahan P; Tseng J; Dunnwald LK; Schubert EK; Pham P; Lewellen B; Mankoff DA
    J Nucl Med; 2003 Jul; 44(7):1044-50. PubMed ID: 12843218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-invasive estimation of the net influx constant using the standardized uptake value for quantification of FDG uptake of tumours.
    Sadato N; Tsuchida T; Nakaumra S; Waki A; Uematsu H; Takahashi N; Hayashi N; Yonekura Y; Ishii Y
    Eur J Nucl Med; 1998 Jun; 25(6):559-64. PubMed ID: 9618569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multifunctional profiling of non-small cell lung cancer using 18F-FDG PET/CT and volume perfusion CT.
    Sauter AW; Winterstein S; Spira D; Hetzel J; Schulze M; Mueller M; Pfannenberg C; Claussen CD; Klotz E; Hann von Weyhern C; Horger MS
    J Nucl Med; 2012 Apr; 53(4):521-9. PubMed ID: 22414637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative evaluation of skeletal tumours with dynamic FDG PET: SUV in comparison to Patlak analysis.
    Wu H; Dimitrakopoulou-Strauss A; Heichel TO; Lehner B; Bernd L; Ewerbeck V; Burger C; Strauss LG
    Eur J Nucl Med; 2001 Jun; 28(6):704-10. PubMed ID: 11440030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatic glucose utilization in hepatic steatosis and obesity.
    Keramida G; Hunter J; Peters AM
    Biosci Rep; 2016 Dec; 36(6):. PubMed ID: 27653524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Normal values for
    Dias AH; Hansen AK; Munk OL; Gormsen LC
    EJNMMI Res; 2022 Mar; 12(1):15. PubMed ID: 35254514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of hepatic steatosis on liver FDG uptake measured in mean standard uptake values.
    Abele JT; Fung CI
    Radiology; 2010 Mar; 254(3):917-24. PubMed ID: 20177102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simplified quantification of FDG metabolism in tumors using the autoradiographic method is less dependent on the acquisition time than SUV.
    Burger IA; Burger C; Berthold T; Buck A
    Nucl Med Biol; 2011 Aug; 38(6):835-41. PubMed ID: 21843779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Imaging proliferation in brain tumors with 18F-FLT PET: comparison with 18F-FDG.
    Chen W; Cloughesy T; Kamdar N; Satyamurthy N; Bergsneider M; Liau L; Mischel P; Czernin J; Phelps ME; Silverman DH
    J Nucl Med; 2005 Jun; 46(6):945-52. PubMed ID: 15937304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multicenter Clinical Trials Using 18F-FDG PET to Measure Early Response to Oncologic Therapy: Effects of Injection-to-Acquisition Time Variability on Required Sample Size.
    Kurland BF; Muzi M; Peterson LM; Doot RK; Wangerin KA; Mankoff DA; Linden HM; Kinahan PE
    J Nucl Med; 2016 Feb; 57(2):226-30. PubMed ID: 26493206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.